DE69615046T2 - 17-alkyl-7-substituierte-4-aza-steroidderivate - Google Patents

17-alkyl-7-substituierte-4-aza-steroidderivate

Info

Publication number
DE69615046T2
DE69615046T2 DE69615046T DE69615046T DE69615046T2 DE 69615046 T2 DE69615046 T2 DE 69615046T2 DE 69615046 T DE69615046 T DE 69615046T DE 69615046 T DE69615046 T DE 69615046T DE 69615046 T2 DE69615046 T2 DE 69615046T2
Authority
DE
Germany
Prior art keywords
treatment
compounds
formula
alpha
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69615046T
Other languages
English (en)
Other versions
DE69615046D1 (de
Inventor
Georgianna Harris
P Sahoo
L Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602855.0A external-priority patent/GB9602855D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69615046D1 publication Critical patent/DE69615046D1/de
Publication of DE69615046T2 publication Critical patent/DE69615046T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69615046T 1995-10-23 1996-10-18 17-alkyl-7-substituierte-4-aza-steroidderivate Expired - Fee Related DE69615046T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US583295P 1995-10-23 1995-10-23
GBGB9602855.0A GB9602855D0 (en) 1996-02-13 1996-02-13 17-Alkyl-7-substituted-4-aza steroid derivatives
PCT/US1996/016786 WO1997015558A1 (en) 1995-10-23 1996-10-18 17-alkyl-7-substituted-4-aza steroid derivatives

Publications (2)

Publication Number Publication Date
DE69615046D1 DE69615046D1 (de) 2001-10-11
DE69615046T2 true DE69615046T2 (de) 2002-06-27

Family

ID=26308666

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69615046T Expired - Fee Related DE69615046T2 (de) 1995-10-23 1996-10-18 17-alkyl-7-substituierte-4-aza-steroidderivate

Country Status (8)

Country Link
EP (1) EP0862556B1 (de)
JP (1) JPH11513711A (de)
AT (1) ATE205193T1 (de)
AU (1) AU722260B2 (de)
CA (1) CA2233862A1 (de)
DE (1) DE69615046T2 (de)
ES (1) ES2160842T3 (de)
WO (1) WO1997015558A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
DE10141984A1 (de) 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
GB0213745D0 (en) * 2002-06-14 2002-07-24 Univ Edinburgh Enzyme
CN107236014A (zh) * 2017-07-26 2017-10-10 广西师范学院 20‑羟基‑孕烯‑3‑芳酯基孕甾化合物及其合成方法和在制备抗肿瘤药物中的应用
CN107236013A (zh) * 2017-07-26 2017-10-10 广西师范学院 20‑羟基‑孕烯‑3‑烷烃酯基孕甾化合物及其合成方法和在制备抗肿瘤药物中的应用
KR102157124B1 (ko) * 2019-12-23 2020-09-18 (주)인벤티지랩 피나스테라이드를 포함하는 서방성 주사용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
HU223613B1 (hu) * 1994-05-19 2004-10-28 Merck & Co. Inc. Új eljárás delta5 szteroidok 7-oxo-származékká történő oxidálására
US5516779A (en) * 1994-06-08 1996-05-14 Merck & Co., Inc. 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors

Also Published As

Publication number Publication date
ES2160842T3 (es) 2001-11-16
JPH11513711A (ja) 1999-11-24
ATE205193T1 (de) 2001-09-15
EP0862556B1 (de) 2001-09-05
CA2233862A1 (en) 1997-05-01
AU722260B2 (en) 2000-07-27
EP0862556A4 (de) 1999-02-03
AU7458296A (en) 1997-05-15
DE69615046D1 (de) 2001-10-11
WO1997015558A1 (en) 1997-05-01
EP0862556A1 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
BR1100217A (pt) Composto, e, composição farmacêutica
ES2149208T3 (es) Inhibidores 4-azaesteroides de 5-alfa-reductasa.
TW270922B (de)
KR960704555A (ko) 5-알파 환원효소 억제제를 사용한 안드로겐성 탄모증의 치료 방법(Method of treating androgenic alopecia with 5-alpha reductase inhibitors)
DE69326008T2 (de) 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren
ATE178795T1 (de) 7-substituierte-4-aza-steroid-derivate als 5- alpha-reductase-hemmer
ATE198274T1 (de) 17 beta-aryl-4-aza-steroidderivate
DK1123082T3 (da) Præparater til topisk applikation af antiandrogent aktive forbindelser
DE69615046T2 (de) 17-alkyl-7-substituierte-4-aza-steroidderivate
BR9203266A (pt) Composto,formulacao farmaceutica,processo para inibir 5alfa-reductase,processos para tratar hiperplasia benigna da prostata,seborreia e alopecia androgenica
ES2099007A1 (es) Derivados de indol.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee